株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオ医薬品:世界市場の概要

Biopharmaceuticals - A Global Market Overview

発行 Industry Experts 商品コード 116879
出版日 ページ情報 英文 486 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
バイオ医薬品:世界市場の概要 Biopharmaceuticals - A Global Market Overview
出版日: 2013年07月15日 ページ情報: 英文 486 Pages
概要

バイオ医薬品市場は2015年に1,825億米ドルに達すると予測されており、2006〜2015年の成長率はCAGR12.4%が見込まれています。

当レポートでは、世界のバイオ医薬品市場の動向について検証し、北米、西欧、アジア太平洋諸国などの地域別動向、市場に参入する企業のプロファイルなどとともに、研究開発、製造動向を交え、概略以下の構成でお届けいたします。

第1章 世界市場の展望

  • イントロダクション
  • 製品区分
    • モノクローナル抗体
    • バイオテクノロジーワクチン
    • エリスロポエチン
    • 顆粒球コロニー刺激因子
    • 組換えヒトインスリン
    • インターフェロン
    • ヒト成長ホルモン
  • 応用分析
    • バイオ医薬品の最終利用市場
    • 主要25品目
  • 市場動向
  • 主な国際企業
  • 主なビジネス動向
  • 主な製品動向
  • 世界市場の概要

第2章 地域市場の展望

  • 市場概要
    • 北米
    • 欧州
    • アジア太平洋地域
    • その他

第3章 産業ガイド

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • ベルギー
    • デンマーク
    • アイルランド
    • ノルウェー
    • スウェーデン
    • スイス
    • オランダ
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 香港
    • インドネシア
    • マレーシア
    • シンガポール
    • 韓国
    • 台湾
  • その他
    • ブラジル
    • イスラエル

第4章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT001

The pharmaceutical R&D pipeline and industry have been witnessing greater degree of dependence on biopharmaceuticals. Development of these products is being undertaken by a growing number of players in the pharmaceutical industry, which include the big pharma companies as also generic drug manufacturers, who are also engaged in developing biosimilars. In conjunction with the traditional small biopharmaceutical companies, the new bigger entrants have been focused on continually expanding the global biologics pipeline, implying that the number and proportion of new pharmaceuticals being commercialized would increasingly comprise biopharmaceuticals and not small molecule drugs. As the cost of developing biopharmaceuticals and bringing them to market is generally much higher, offering enhanced profit margins, it comes as no surprise that the global pharmaceutical industry would continue to rely on biopharmaceuticals for profits and innovation, in addition to its very survival.

Even though the worldwide economic recession has been slow in recovering, the global pharmaceutical and biopharmaceutical industries have marched ahead, showing profitability and growth. According to estimates, more than 10k therapeutics are currently in the research and development stage, which include chemical substance pharmaceuticals or drugs and biotechnology-derived pharmaceuticals or biopharmaceuticals undergoing over 40k clinical trials. This translates into a significant increase from as little as half-a-decade back, indicating a conspicuous shift in the pharmaceutical industry from developing small molecule drugs to biopharmaceuticals for obtaining novel, ground-breaking and profitable solutions.

The report reviews, analyses and projects the biopharmaceuticals market (2010-2020) for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America - The United States, Canada and Mexico; Europe - Germany, the United Kingdom, France, Italy, Spain and Russia; Asia-Pacific - Japan, China and India; South America - Argentina and Brazil.

Biopharmaceuticals product segments analyzed in this study comprises Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and others. Therapeutic areas analyzed include Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and others. Biopharmaceuticals market, estimated at US$199.7 billion globally in 2013, is further projected to reach US$497.9 billion by 2020, growing at 13.5% CAGR between 2010 and 2020. Among different product segments, monoclonal antibodies (moAb) constitutes the largest product segment in the global biopharmaceuticals market accounting for an estimated share of 25.6% in 2013, equating to US$51.1 billion. In terms of therapeutic area, neurology applications is the largest market for global biopharmaceuticals with an estimated 2013 share of 28.2% valued at US$56.3 billion, and further expected reach a projected US$144.5 billion by 2020.

The study includes 249 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market by geographic region, product segment and therapeutic area. This study profiles 25 key global players and 70 major players across North America - 24; Europe - 17; Asia-Pacific - 27 and Rest of World - 2. The report also provides the listing of the companies engaged in research and development, manufacturing and supply of biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 492 companies.

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1. Evolution of the Industry
  • 1.2. Product Outline
    • 1.2.1. What are biopharmaceuticals?
      • 1.2.1.1. Description of Biopharmaceuticals
      • 1.2.1.2. Commercialization of Biopharmaceuticals
      • 1.2.1.3. Regulation of Biopharmaceuticals
      • 1.2.1.4. Principal Categories of Biopharmaceuticals and their Uses
      • 1.2.1.5. Large Scale Production of Biopharmaceuticals
        • 1.2.1.5.1. Transgenic
    • 1.2.2. Categorization of Biopharmaceuticals
      • 1.2.2.1. Monoclonal Antibodies
        • 1.2.2.1.1. Production of Monoclonal Antibodies
        • 1.2.2.1.2. Primary Applications of Monoclonal Antibodies
        • 1.2.2.1.3. Anti-Inflammatory Monoclonal Antibodies
        • 1.2.2.1.4. Anti-Cancer Monoclonal Antibodies
        • 1.2.2.1.5. Other Monoclonal Antibodies
        • 1.2.2.1.6. Therapeutic Applications of Monoclonal Antibodies
        • 1.2.2.1.7. Therapeutic Monoclonal Antibodies Approved by the FDA
      • 1.2.2.2. Erythropoietin (EPO)
        • 1.2.2.2.1. Functions of EPO
        • 1.2.2.2.2. Medical Uses of EPO
          • 1.2.2.2.2.1. Available Forms of EPO
      • 1.2.2.3. Biotech Vaccines
        • 1.2.2.3.1. Categories of Vaccines
        • 1.2.2.3.2. Recombinant Vector Vaccines
        • 1.2.2.3.3. Production of Recombinant Vector Vaccines
        • 1.2.2.3.4. Positives and Negatives of Recombinant Vector Vaccines
      • 1.2.2.4. Recombinant Human (RH) Insulin
        • 1.2.2.4.1. Production of RH Insulin
      • 1.2.2.5. Granulocyte Colony-Stimulating Factor (G-CSF)
        • 1.2.2.5.1. Biological Role of G-CSF
        • 1.2.2.5.2. Therapeutic Applications of G-CSF
        • 1.2.2.5.3. Some Highlights of G-CSF
      • 1.2.2.6. Interferons (IFNs)
        • 1.2.2.6.1. Types of Interferons
        • 1.2.2.6.2. Functions of Interferons
        • 1.2.2.6.3. Disease Therapy with Interferons
        • 1.2.2.6.4. Interferons and Drug Formulations
      • 1.2.2.7. Human Growth Hormones
        • 1.2.2.7.1. The Functioning of Human Growth Hormone
        • 1.2.2.7.2. Clinical Importance of HGH
        • 1.2.2.7.3. Use of HGH as a Medication
      • 1.2.2.8. Other Biopharmaceuticals
        • 1.2.2.8.1. Blood Factors (Factor VIII and Factor IX)
          • 1.2.2.8.1.1. Factor VIII
          • 1.2.2.8.1.2. Factor IX
        • 1.2.2.8.2. Thrombolytic Agents (Tissue Plasminogen Activator)
        • 1.2.2.8.3. Interleukin-Based Products
          • 1.2.2.8.3.1. Human Interleukins
        • 1.2.2.8.4. Tumor Necrosis Factor
        • 1.2.2.8.5. Therapeutic Enzymes

2. KEY FACTS AND FIGURES OF BIOPHARMA INDUSTRY AND LATEST APPROVALS

  • 2.1. Some Key Facts about the Biopharmaceutical Industry
  • 2.2. Biopharmaceuticals Approved by the USFDA in 2012 and 2013(To Date)

3. KEY MARKET TRENDS

  • 3.1. Enhancing Industry Health and Standing
  • 3.2. Spending and Investment in Biopharmaceuticals Rising
  • 3.3. Shifts in Outsourcing Trends
  • 3.4. Continuing but Slowing Mega M&A Activity with More Emphasis on Strategy
  • 3.5. New and Small Companies Feeling the Pinch
  • 3.6. Can “BRICS” Build Up the Biopharmaceutical Industry?
  • 3.7. What Ails the Biopharmaceutical Product Pipeline?
  • 3.8. R&D in Biopharmaceuticals Surpassing Drug R&D
  • 3.9. Biopharmaceutical Companies Going Global
  • 3.10. Developing Countries Forging Ahead with Biopharmaceutical Manufacturing
  • 3.11. Manufacturing Processes Attaining Global Standardization
  • 3.12. In Conclusion

4. KEY GLOBAL PLAYERS

  • Abbott Laboratories, Inc.
  • Amgen, Inc.
  • Astrazeneca PLC
  • BASF SE
  • Bayer AG
  • Biocon Ltd.
  • Biogen Idec
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company Limited
  • Eli Lilly and Company
  • Genentech, Inc.
  • Glaxosmithkline, PLC
  • Hospira, Inc.
  • Johnson & Johnson, Inc.
  • LG Life Sciences
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Ranbaxy Laboratories Ltd.
  • Roche Holding AG
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A

5. KEY BUSINESS TRENDS

  • Completion of Inspiration's Hemophilia Products Sale
  • Novozymes Biopharma and EpiVax Ink Research Agreement
  • Glenmark Pharmaceuticals SA Discovers and Initiates IND Studies for GBR 830
  • Navidea Establishes Strategic Alliance with Maimonides Medical Center
  • Bayer and Regeneron Kickoffs VEGF Trap-Eye Phase III Trial to Treat DME
  • Novartis Kickoffs Biopharmaceutical Unit Construction
  • Roche Partners Chiasma on Octreolin Development and Commercialization
  • Partnership between Refine Technology and Gallus BioPharmaceuticals for Continuous Cell Culture Processing
  • Navidea Biopharmaceuticals Completes NAV4694's Clinical Trial
  • GVK Biosciences Inks Collaboration with Onconova therapeutics on Novel Cancer Drugs
  • Completion of Abbott's Research-based Pharmaceuticals Business Spin-off Forms AbbVie
  • Bio-Rad Launches 2-DE/WB workflow for Anti-HCP Antibodies Assessment
  • Novozymes biopharma Unveils New Brand for its rAlbumin Product Line
  • Expansion of Cytovance Biologics' mammalian production capabilities in 2013
  • GlaxoSmithKline Partners with Biological E. for Combination Vaccine Development
  • Baxter Takes Over Inspiration's OBI-1 Assets
  • BASF Acquires Pronova BioPharma
  • Sutro Biopharma and Sanofi Pasteur form Alliance on Vaccine Production
  • Development of Pertussis mAb therapies Started by Synthetic Biologics and Intrexon Corporation
  • Teva Pharmaceuticals Establishes Strategic Alliance with Galena Biopharma on NeuVax
  • FDA Approves MycoTOOL PCR Mycoplasma Detection Kit of Roche
  • Boehringer Inks Manufacturing Supply Agreement with Apexigen for Cancer mAbs
  • Merck Signs Agreement with GE Healthcare to Use [18F] Flutemetamol for the Development of
  • MK-8931, BACE Inhibitor for AD
  • Galena Biopharma Collaborates with Leica Biosystems for HER2 Companion Diagnostic Development
  • ProMetic Life Sciences in Collaboration with NantPharma Develop Second Plasma-derived Biopharmaceutical
  • Pamorelin LA of Debiopharm Unveiled by Dr. Reddy's in India to Treat Prostate Cancer
  • Inspiration's OBI-1 for Acquired Hemophilia A Receives FDA's Fast Track Designation
  • New Licensed Biopharmaceuticals Produced by Fujifilm Diosynth Biotechnologies
  • PAREXEL Establishes a Strategic Alliance with National Taiwan University Hospital
  • SAFC Broadens the line of PharmaGrade Raw Materials for Biopharmaceutical Production
  • ActoGeniX and Merck Form Research Pact
  • Sandoz Biopharmaceuticals Inaugurates Cellular and Molecular Biology Laboratory in Menges
  • Boehringer Ingelheim Introduces Smart-to-Launch Fast Track Project Transfer Process
  • Launch of Biopharmaceutical Contract Manufacturing Offering by Olympus Biotech
  • SAFC Establishes Strategic Alliance with CrystalGenomics
  • Global Phase 3 Study for Recombinant Human Insulin of Biocon Achieves Positive Outcome
  • Fujifilm Diosynth Partners with Piramal Healthcare in ADCs Contract Manufacturing
  • DSM Collaborates with Paranta Biosciences
  • Wacker Biotech Partners with XL-protein for PASylated Therapeutic Proteins Production
  • Implementation of Boehringer Ingelheim's Flexible Biopharmaceutical Disposable Set-up
  • KUBio, Modular Biopharmaceutical Factory Inaugurated by GE Healthcare
  • Synthetic Biologics Kickoffs the Development of mAbs to Treat Acinetobacter Infections
  • Gallus BioPharmaceuticals Establishes Strategic Alliance with Roslin Cells for Cell Therapeutics' Supply
  • Constellation Pharmaceuticals Forms Strategic Alliance with The Leukemia & Lymphoma Society on BET Inhibitor Development
  • Evotec AG Inks Collaboration with Aspireo
  • Boehringer Ingelheim Inks Collaboration with Servier and XOMA
  • Biochrom AG Acquired by Merck KGaA
  • Gallus BioPharmaceuticals Partners with Natrix Separations Inc.
  • Collaboration between Theorem Clinical Research and Gallus BioPharmaceuticals
  • GE Healthcare Establishes Strategic Alliance with iBio for Using Plant-based Technologies in Biopharmaceuticals Production
  • Daiichi Sankyo Plans to Initiate Japanese Ministry's Biopharmaceuticals Unit Construction
  • Inspiration Biopharmaceuticals Places its Two IB1001 Clinical Trials on Hold
  • ProMetic Life Sciences Inks Collaboration with NantPharma for Plasma-derived Biopharmaceutical Development
  • Unveiling Bristol-Myers Squibb's Coverage with US$35 Trefis Price Estimate
  • Saint-Gobain Introduces C-Flex ULTRA Pump Tubing Excelling the Competition
  • Launch of Boehringer Ingelheim's Typical Brand Boehringer Ingelheim BioXcellence
  • Merck KGaA Establishes Alliance with Dr Reddy's to Develop Biosimilar mAbs
  • Strategic Alliance of DSM to Offer Contract Manufacturing Services
  • Bharat Biotech and University of Maryland to Collaborate on iNTS Vaccine Development
  • Collaboration between Daiichi Sankyo and Coherus BioSciences on Biosimilars
  • Grace and Formac Pharmaceuticals Completes Silica-Based Drug Delivery Technology's Clinical Trial
  • Celltrion Steps into CMO Business for Novel Drugs Production in Korea
  • Research Organics Acquired by Sigma-Aldrich
  • Introduction of Lean-to-Clinic Program by Boehringer Ingelheim
  • GE Healthcare Acquires Xcellerex to Spread out its Competences in the Emerging Biopharmaceutical Industry
  • Daiichi Sankyo Signs Research Collaboration and License Agreement with NGM
  • GE Healthcare Plans to Acquire Xcellerex to Enhance Biopharma Potencies
  • Expansion of Boehringer Ingelheim's Biopharmaceutical Process Science Capabilities
  • Morria Biopharmaceuticals and Scynexis form Alliance to Sustain MRX-4 Activities
  • Boehringer Ingelheim Establishes Strategic Alliance with Xencor to Develop, Produce and Commercialize Biosuperior mAbs
  • Sigma-Aldrich Acquires BioReliance to Advance Biopharmaceuticals Production
  • Sigma-Aldrich Plans BioReliance Acquisition to Offer Biopharmaceutical Testing and Services
  • Bristol-Myers Squibb Marks Merger Agreement with Inhibitex
  • Initiation of Hospira's Biosimilar EPO Phase III Clinical Trial in US
  • Strategic Alliance between GE Healthcare and M+W Group
  • Lonza Unveils pDNA Production Platform to Produce Microbial Biopharmaceuticals
  • Repligen Acquires Novozymes Biopharma Sweden AB
  • Simcere Inks Collaboration with Bristol-Myers Squibb for Developing BMS-795311
  • Novozymes Biopharma Partners with R-Tech Ueno to Supply Albucult
  • Inspiration Biopharmaceuticals starts the Second OBI-1's Accur8 Clinical Trial
  • ASLAN Pharmaceuticals and Bristol-Myers Squibb form BMS-777607 Development Pact
  • Fujifilm Diosynth Biotechnologies Partners with ContraFect Corporation to Develop and Manufacture CF-301
  • Bayer HealthCare Restructure Collaboration with Onyx Pharmaceuticals
  • Boehringer Ingelheim Receives Frost & Sullivan Award for Biopharmaceutical Contract Manufacturing
  • Biocon Heralds Project Initiation to Establish Biopharmaceutical Manufacturing and R&D Unit in Bio-XCell
  • CMC Biologics and Inspiration Biopharmaceuticals Collaborate on IB1001 Manufacture
  • Expansion of Boehringer Ingelheim's Fill and Finish Competences for Biopharmaceuticals
  • Introduction of BD Recharge by BD Biosciences to Augment Biopharmaceutical Protein Production
  • Fujifilm Partners with Mitsubishi in Biopharmaceutical Contract Manufacturing
  • Expansion of Fujifilm Diosynth Biotechnologies' Mammalian Cell Culture Capacity
  • Xcellerex Inks Collaboration with Gallus BioPharmaceuticals
  • Strategic License Agreement between Sanofi and Glenmark Pharmaceuticals on GBR500
  • Inauguration of EMD Millipore's Biopharmaceutical Technical Center in Shanghai
  • Novozymes Biopharma Launches Albufuse Flex Technology Developed by Joining Forces with the University of Oslo
  • Amgen's Biopharmaceutical Development and Manufacturing Unit Acquired by Boehringer Ingelheim
  • Unveiling of All-in-one Chromatography System of Bio-Rad
  • Forest Laboratories and Allergy Asthma Research Institute Fall in SAFE-BioPharma Association
  • Ipsen Establishes Strategic alliance with bioMérieux in Theranostics
  • Inspiration Biopharmaceuticals Demonstrates Non-inferiority of IB1001

6. GLOBAL MARKET OVERVIEW

  • 6.1. Global Market by Product Segment
    • 6.1.1. Biopharmaceutical Product Market Overview by Global Region
      • 6.1.1.1. Monoclonal Antibodies (moAb)
      • 6.1.1.2. Erythropoietin
      • 6.1.1.3. Biotech Vaccines
      • 6.1.1.4. Recombinant Human (RH) Insulin
      • 6.1.1.5. Granulocyte Colony-Stimulating Factor (G-CSF)
      • 6.1.1.6. Interferons
      • 6.1.1.7. Human Growth Hormones (HGH)
      • 6.1.1.8. Other Biopharmaceuticals
  • 6.2. Global Market by Therapeutic Area
    • 6.2.1. Biopharmaceutical Therapeutic Area Market Overview by Global Region
      • 6.2.1.1. Neurology
      • 6.2.1.2. Infectious Diseases
      • 6.2.1.3. Diabetes
      • 6.2.1.4. Oncology
      • 6.2.1.5. Cardiovascular
      • 6.2.1.6. Other Therapeutic Areas

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

1. NORTH AMERICA

  • 1.1. North American Biopharmaceutical Market by Geographic Region
  • 1.2. North American Biopharmaceutical Market by Product Segment
    • 1.2.1. Biopharmaceutical Product Market Overview by North American Region
      • 1.2.1.1. Monoclonal Antibodies (moAb)
      • 1.2.1.2. Erythropoietin
      • 1.2.1.3. Biotech Vaccines
      • 1.2.1.4. Recombinant Human (RH) Insulin
      • 1.2.1.5. Granulocyte Colony-Stimulating Factor (G-CSF)
      • 1.2.1.6. Interferons
      • 1.2.1.7. Human Growth Hormones (HGH)
      • 1.2.1.8. Other Biopharmaceuticals
  • 1.3. North American Biopharmaceutical Market by Therapeutic Area
    • 1.3.1. Biopharmaceutical Therapeutic Area Market Overview by North American Region
      • 1.3.1.1. Neurology
      • 1.3.1.2. Infectious Diseases
      • 1.3.1.3. Diabetes
      • 1.3.1.4. Oncology
      • 1.3.1.5. Cardiovascular
      • 1.3.1.6. Other Therapeutic Areas
  • 1.4. Major Market Players
    • Abbott Laboratories, Inc.
    • Alder Biopharmaceuticals Inc.
    • Alexion Pharmaceuticals, Inc
    • Amgen, Inc.
    • Analytical Biological Services Inc
    • Array Biopharma Inc.
    • Atlanta Biologicals, Inc
    • Baxter Bioscience Inc
    • Biogen Idec
    • Bristol-Myers Squibb Company
    • Charles River Laboratories International, Inc.
    • Eli Lilly and Company
    • Fujifilm Diosynth Biotechnologies
    • Genentech, Inc.
    • Genzyme Corporation
    • Hospira, Inc.
    • Johnson & Johnson
    • Millennium Pharmaceuticals, Inc.
    • Novozymes Biopharma US, Inc.
    • Onyx Pharmaceuticals, Inc.
    • Pfizer Inc
    • Seattle Genetics, Inc
    • Soligenix, Inc.
    • Teva North America
  • 1.5. North American Biopharmaceutical Market Overview by Country
    • 1.5.1. THE UNITED STATES
      • 1.5.1.1. Biopharmaceutical Market by Product Segment
      • 1.5.1.2. Biopharmaceutical Market by Therapeutic Area
    • 1.5.2. CANADA
      • 1.5.2.1. Biopharmaceutical Market by Product Segment
      • 1.5.2.2. Biopharmaceutical Market by Therapeutic Area
    • 1.5.3. MEXICO
      • 1.5.3.1. Biopharmaceutical Market by Product Segment
      • 1.5.3.2. Biopharmaceutical Market by Therapeutic Area

2. EUROPE

  • 2.1. European Biopharmaceutical Market by Geographic Region
  • 2.2. European Biopharmaceutical Market by Product Segment
    • 2.2.1. Biopharmaceutical Product Market Overview by European Region
      • 2.2.1.1. Monoclonal Antibodies (moAb)
      • 2.2.1.2. Erythropoietin
      • 2.2.1.3. Biotech Vaccines
      • 2.2.1.4. Recombinant Human (RH) Insulin
      • 2.2.1.5. Granulocyte Colony-Stimulating Factor (G-CSF)
      • 2.2.1.6. Interferons
      • 2.2.1.7. Human Growth Hormones (HGH)
      • 2.2.1.8. Other Biopharmaceuticals
  • 2.3. European Biopharmaceutical Market by Therapeutic Area
    • 2.3.1. Biopharmaceutical Therapeutic Area Market Overview by European Region
      • 2.3.1.1. Neurology
      • 2.3.1.2. Infectious Diseases
      • 2.3.1.3. Diabetes
      • 2.3.1.4. Oncology
      • 2.3.1.5. Cardiovascular
      • 2.3.1.6. Other Therapeutic Areas
  • 2.4. Major Market Players
    • 3P Biopharmaceuticals S.L. (Spain)
    • Applikon Biotechnology B.V. (The Netherlands)
    • Astrazeneca Plc (United Kingdom)
    • BASF SE (Germany)
    • Bayer AG (Germany)
    • Boehringer Ingelheim GmbH (Germany)
    • Cellgenix GmbH (Germany)
    • Evotec AG (Germany)
    • Glaxosmithkline, PLC (United Kingdom)
    • Merck Serono S.A. (Switzerland)
    • Novartis AG (Switzerland)
    • Novo Nordisk A/S (Denmark)
    • Novozymes A/S (Denmark)
    • Pronova Biopharma ASA (Norway)
    • Roche Holding AG (Switzerland)
    • Sanofi (France)
    • UCB S.A. (Belgium)
  • 2.5. European Biopharmaceutical Market Overview by Country
    • 2.5.1. GERMANY
      • 2.5.1.1. Biopharmaceutical Market by Product Segment
      • 2.5.1.2. Biopharmaceutical Market by Therapeutic Area
    • 2.5.2. THE UNITED KINGDOM
      • 2.5.2.1. Biopharmaceutical Market by Product Segment
      • 2.5.2.2. Biopharmaceutical Market by Therapeutic Area
    • 2.5.3. FRANCE
      • 2.5.3.1. Biopharmaceutical Market by Product Segment
      • 2.5.3.2. Biopharmaceutical Market by Therapeutic Area
    • 2.5.4. ITALY
      • 2.5.4.1. Biopharmaceutical Market by Product Segment
      • 2.5.4.2. Biopharmaceutical Market by Therapeutic Area
    • 2.5.5. SPAIN
      • 2.5.5.1. Biopharmaceutical Market by Product Segment
      • 2.5.5.2. Biopharmaceutical Market by Therapeutic Area
    • 2.5.6. RUSSIA
      • 2.5.6.1. Biopharmaceutical Market by Product Segment
      • 2.5.6.2. Biopharmaceutical Market by Therapeutic Area
    • 2.5.7. REST OF EUROPE
      • 2.5.7.1. Biopharmaceutical Market by Product Segment
      • 2.5.7.2. Biopharmaceutical Market by Therapeutic Area

3. ASIA-PACIFIC

  • 3.1. Asia-Pacific Biopharmaceuticals Market by Geographic Region
  • 3.2. Asia-Pacific Biopharmaceuticals Market by Product Segment
    • 3.2.1. Biopharmaceutical Product Market Overview by Asia-Pacific Region
      • 3.2.1.1. Monoclonal Antibodies (moAb)
      • 3.2.1.2. Erythropoietin
      • 3.2.1.3. Biotech Vaccines
      • 3.2.1.4. Recombinant Human (RH) Insulin
      • 3.2.1.5. Granulocyte Colony-Stimulating Factor (G-CSF)
      • 3.2.1.6. Interferons
      • 3.2.1.7. Human Growth Hormones (HGH)
      • 3.2.1.8. Other Biopharmaceuticals
  • 3.3. Asia-Pacific Biopharmaceuticals Market by Therapeutic Area
    • 3.3.1. Biopharmaceutical Therapeutic Area Market Overview by Asia-Pacific Region
      • 3.3.1.1. Neurology
      • 3.3.1.2. Infectious Diseases
      • 3.3.1.3. Diabetes
      • 3.3.1.4. Oncology
      • 3.3.1.5. Cardiovascular
      • 3.3.1.6. Other Therapeutic Areas
  • 3.4. Major Market Players
    • Aurobindo Pharma Ltd. (India)
    • Beijing Sl Pharmaceutical Co Ltd (China)
    • Beijing Tiantan Biological Products Co Ltd (China)
    • Biocon Ltd. (India)
    • Biological E Limited (India)
    • Bukwang Pharmaceutical Co Ltd (South Korea)
    • Cadila Healthcare Limited (Zydus Cadila) (India)
    • Celltrion, Inc. (South Korea)
    • Cipla Ltd (India)
    • Daiichi Sankyo Company Limited (Japan)
    • Dainippon Sumitomo Pharma Co Ltd (Japan)
    • Glenmark Pharmaceuticals Limited (India)
    • GVK Biosciences Pvt Ltd (India)
    • Hualan Biological Engineering Inc (China)
    • LG Life Sciences (South Korea)
    • Ranbaxy Laboratories Ltd. (India)
    • RPG Life Sciences Limited (India)
    • Reliance Life Sciences Pvt Ltd (India)
    • Samsung Biologics Co Ltd (South Korea)
    • Sanofi India Limited (India)
    • SciGen Ltd. (Singapore)
    • Shanghai Institute of Biological Products (China)
    • Shantha Biotechnics Ltd (India)
    • Sun Pharmaceutical Industries Ltd (India)
    • Suven Life Sciences Ltd (India)
    • Takeda Pharmaceutical Company Limited (Japan)
    • Torrent Pharmaceuticals Limited (India)
  • 3.5. Asia-Pacific Biopharmaceuticals Market by Country
    • 3.5.1. JAPAN
      • 3.5.1.1. Biopharmaceuticals Market by Product Segment
      • 3.5.1.2. Biopharmaceuticals Market by Therapeutic Area
    • 3.5.2. CHINA
      • 3.5.2.1. Biopharmaceuticals Market by Product Segment
      • 3.5.2.2. Biopharmaceuticals Market by Therapeutic Area
    • 3.5.3. INDIA
      • 3.5.3.1. Biopharmaceuticals Market by Product Segment
      • 3.5.3.2. Biopharmaceuticals Market by Therapeutic Area
    • 3.5.4. REST OF ASIA-PACIFIC
      • 3.5.4.1. Biopharmaceuticals Market by Product Segment
      • 3.5.4.2. Biopharmaceuticals Market by Therapeutic Area

4. SOUTH AMERICA

  • 4.1. South American Biopharmaceuticals Market by Geographic Region
  • 4.2. South American Biopharmaceuticals Market by Product Segment
    • 4.2.1. Biopharmaceutical Product Market Overview by South American Region
      • 4.2.1.1. Monoclonal Antibodies (moAb)
      • 4.2.1.2. Erythropoietin
      • 4.2.1.3. Biotech Vaccines
      • 4.2.1.4. Recombinant Human (RH) Insulin
      • 4.2.1.5. Granulocyte Colony-Stimulating Factor (G-CSF)
      • 4.2.1.6. Interferons
      • 4.2.1.7. Human Growth Hormones (HGH)
      • 4.2.1.8. Other Biopharmaceuticals
  • 4.3. South American Biopharmaceuticals Market by Therapeutic Area
    • 4.3.1. Biopharmaceutical Therapeutic Area Market Overview by South American Region
      • 4.3.1.1. Neurology
      • 4.3.1.2. Infectious Diseases
      • 4.3.1.3. Diabetes
      • 4.3.1.4. Oncology
      • 4.3.1.5. Cardiovascular
      • 4.3.1.6. Other Therapeutic Areas
  • 4.4. South American Biopharmaceutical Market by Country
    • 4.4.1. ARGENTINA
      • 4.4.1.1. Biopharmaceutical Market by Product Segment
      • 4.4.1.2. Biopharmaceutical Market by Therapeutic Area
    • 4.4.2. BRAZIL
      • 4.4.2.1. Biopharmaceutical Market by Product Segment
      • 4.4.2.2. Biopharmaceutical Market by Therapeutic Area
    • 4.4.3. REST OF SOUTH AMERICA
      • 4.4.3.1. Biopharmaceutical Market by Product Segment
      • 4.4.3.2. Biopharmaceutical Market by Therapeutic Area

5. REST OF WORLD

  • 5.1. Rest of World Biopharmaceutical Market by Product Segment
  • 5.2. Rest of World Biopharmaceutical Market by Therapeutic Area
  • 5.3. Major Market Players
    • D-Pharm Ltd. (Israel)
    • Teva Pharmaceutical Industries Ltd. (Israel)

PART C: GUIDE TO THE INDUSTRY

1. NORTH AMERICA

  • 1.1. Canada
  • 1.2. United States

2. EUROPE

  • 2.1. Austria
  • 2.2. Belgium
  • 2.3. Denmark
  • 2.4. France
  • 2.5. Germany
  • 2.6. Ireland
  • 2.7. Lithuania
  • 2.8. Norway
  • 2.9. Spain
  • 2.10. Sweden
  • 2.11. Switzerland
  • 2.12. The Netherlands
  • 2.13. United Kingdom

3. ASIA-PACIFIC

  • 3.1. Australia
  • 3.2. China
  • 3.3. Hong Kong
  • 3.4. India
  • 3.5. Indonesia
  • 3.6. Japan
  • 3.7. Malaysia
  • 3.8. Singapore
  • 3.9. South Korea
  • 3.10. Taiwan

4. REST OF WORLD

  • 4.1. Brazil
  • 4.2. Israel

PART D: ANNEXURE

1. RESEARCH METHODOLOGY

2. THE QUESTIONNAIRE

3. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Evolution of Biopharma Industry in Past Decade (2004-2013)
  • Chart 2: The FDA Approved Monoclonal Antibodies - Antibody, Brand, Company, Mechanism of Action and Indication
  • Chart 3: Forms of EPO - EPO Form, Drug Name and Manufacturer
  • Chart 4: Types of Human Interferons based on Type of Receptor Used in Signaling - Interferon Type I, Interferon Type II and Interferon Type III
  • Chart 5: The List of Interleukins (IL-1 to IL 36) - Interleukin Name, Source, Target Receptors, Target Cells and Function
  • Chart 6: Global Biopharmaceuticals Market Analysis (2010-2020) in US$ Million
  • Chart 7: Global Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 8: Glance at 2010, 2015 and 2020 Global Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 9: Global Monoclonal Antibodies (moAb) Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 10: Glance at 2010, 2015 and 2020 Global Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 11: Global Erythropoietin Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 12: Glance at 2010, 2015 and 2020 Global Erythropoietin Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 13: Global Biotech Vaccines Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 14: Glance at 2010, 2015 and 2020 Global Biotech Vaccines Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 15: Global Recombinant Human (RH) Insulin Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 16: Glance at 2010, 2015 and 2020 Global Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 17: Global Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 18: Glance at 2010, 2015 and 2020 Global Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 19: Global Interferons Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 20: Glance at 2010, 2015 and 2020 Global Interferons Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 21: Global Human Growth Hormones (HGH) Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 22: Glance at 2010, 2015 and 2020 Global Human Growth Hormones (HGH) Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 23: Global Other Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 24: Glance at 2010, 2015 and 2020 Global Other Biopharmaceuticals Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 25: Global Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 26: Glance at 2010, 2015 and 2020 Global Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas
  • Chart 27: Global Biopharmaceuticals in Neurology Therapy Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 28: Glance at 2010, 2015 and 2020 Global Biopharmaceuticals in Neurology Market Therapy Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 29: Global Biopharmaceuticals in Infectious Diseases Therapy Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 30: Glance at 2010, 2015 and 2020 Global Biopharmaceuticals in Infectious Diseases Therapy Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 31: Global Biopharmaceuticals in Diabetes Therapy Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 32: Glance at 2010, 2015 and 2020 Global Biopharmaceuticals in Diabetes Therapy Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 33: Global Biopharmaceuticals in Oncology Therapy Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 34: Glance at 2010, 2015 and 2020 Global Biopharmaceuticals in Oncology Therapy Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 35: Global Biopharmaceuticals in Cardiovascular Therapy Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 36: Glance at 2010, 2015 and 2020 Global Biopharmaceuticals in Cardiovascular Therapy Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 37: Global Biopharmaceuticals in Other Therapeutic Areas Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 38: Glance at 2010, 2015 and 2020 Global Biopharmaceuticals in Other Therapeutic Areas Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 39: The Projection of Prospective Regions in terms of Market Growth for Biopharmaceuticals by Geography - Asia-Pacific, South America, Europe and North America
  • Chart 40: Global Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in US$ Million
  • Chart 41: Glance at 2010, 2015 and 2020 Global Biopharmaceuticals Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World

NORTH AMERICA

  • Chart 42: North American Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 43: Glance at 2010, 2015 and 2020 North American Biopharmaceuticals Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 44: North American Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 45: Glance at 2010, 2015 and 2020 North American Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 46: North American Monoclonal Antibodies (moAb) Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 47: Glance at 2010, 2015 and 2020 North American Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 48: North American Erythropoietin Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 49: Glance at 2010, 2015 and 2020 North American Erythropoietin Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 50: North American Biotech Vaccines Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 51: Glance at 2010, 2015 and 2020 North American Biotech Vaccines Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 52: North American Recombinant Human (RH) Insulin Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 53: Glance at 2010, 2015 and 2020 North American Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 54: North American Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 55: Glance at 2010, 2015 and 2020 North American Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 56: North American Interferons Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 57: Glance at 2010, 2015 and 2020 North American Interferons Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 58: North American Human Growth Hormones (HGH) Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 59: Glance at 2010, 2015 and 2020 North American Human Growth Hormones (HGH) Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 60: North American Other Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 61: Glance at 2010, 2015 and 2020 North American Other Biopharmaceuticals Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 62: North American Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 63: Glance at 2010, 2015 and 2020 North American Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas
  • Chart 64: North American Biopharmaceuticals in Neurology Therapy Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 65: Glance at 2010, 2015 and 2020 North American Biopharmaceuticals in Neurology Market Therapy Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 66: North American Biopharmaceuticals in Infectious Diseases Therapy Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 67: Glance at 2010, 2015 and 2020 North American Biopharmaceuticals in Infectious Diseases Therapy Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 68: North American Biopharmaceuticals in Diabetes Therapy Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 69: Glance at 2010, 2015 and 2020 North American Biopharmaceuticals in Diabetes Therapy Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 70: North American Biopharmaceuticals in Oncology Therapy Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 71: Glance at 2010, 2015 and 2020 North American Biopharmaceuticals in Oncology Therapy Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 72: North American Biopharmaceuticals in Cardiovascular Therapy Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 73: Glance at 2010, 2015 and 2020 North American Biopharmaceuticals in Cardiovascular Therapy Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 74: North American Biopharmaceuticals in Other Therapeutic Areas Market Analysis (2010-2020) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 75: Glance at 2010, 2015 and 2020 North American Biopharmaceuticals in Other Therapeutic Areas Market Share (%) by Geographic Region - United States, Canada and Mexico

THE UNITED STATES

  • Chart 76: United States Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 77: Glance at 2010, 2015 and 2020 United States Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 78: United States Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 79: Glance at 2010, 2015 and 2020 United States Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

CANADA

  • Chart 80: Canadian Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 81: Glance at 2010, 2015 and 2020 Canadian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 82: Canadian Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 83: Glance at 2010, 2015 and 2020 Canadian Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

MEXICO

  • Chart 84: Mexican Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 85: Glance at 2010, 2015 and 2020 Mexican Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 86: Mexican Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 87: Glance at 2010, 2015 and 2020 Mexican Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

EUROPE

  • Chart 88: European Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 89: Glance at 2010, 2015 and 2020 European Biopharmaceuticals Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 90: European Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 91: Glance at 2010, 2015 and 2020 European Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 92: European Monoclonal Antibodies (moAb) Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 93: Glance at 2010, 2015 and 2020 European Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 94: European Erythropoietin Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 95: Glance at 2010, 2015 and 2020 European Erythropoietin Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 96: European Biotech Vaccines Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 97: Glance at 2010, 2015 and 2020 European Biotech Vaccines Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 98: European Recombinant Human (RH) Insulin Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 99: Glance at 2010, 2015 and 2020 European Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 100: European Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 101: Glance at 2010, 2015 and 2020 European Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 102: European Interferons Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 103: Glance at 2010, 2015 and 2020 European Interferons Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 104: European Human Growth Hormones (HGH) Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 105: Glance at 2010, 2015 and 2020 European Human Growth Hormones (HGH) Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 106: European Other Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 107: Glance at 2010, 2015 and 2020 European Other Biopharmaceuticals Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 108: European Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 109: Glance at 2010, 2015 and 2020 European Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas
  • Chart 110: European Biopharmaceuticals in Neurology Therapy Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 111: Glance at 2010, 2015 and 2020 European Biopharmaceuticals in Neurology Market Therapy Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 112: European Biopharmaceuticals in Infectious Diseases Therapy Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 113: Glance at 2010, 2015 and 2020 European Biopharmaceuticals in Infectious Diseases Therapy Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 114: European Biopharmaceuticals in Diabetes Therapy Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 115: Glance at 2010, 2015 and 2020 European Biopharmaceuticals in Diabetes Therapy Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 116: European Biopharmaceuticals in Oncology Therapy Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 117: Glance at 2010, 2015 and 2020 European Biopharmaceuticals in Oncology Therapy Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 118: European Biopharmaceuticals in Cardiovascular Therapy Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 119: Glance at 2010, 2015 and 2020 European Biopharmaceuticals in Cardiovascular Therapy Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe
  • Chart 120: European Biopharmaceuticals in Other Therapeutic Areas Market Analysis (2010-2020) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe in US$ Million
  • Chart 121: Glance at 2010, 2015 and 2020 European Biopharmaceuticals in Other Therapeutic Areas Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe

GERMANY

  • Chart 122: German Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 123: Glance at 2010, 2015 and 2020 German Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 124: German Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 125: Glance at 2010, 2015 and 2020 German Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

THE UNITED KINGDOM

  • Chart 126: United Kingdom Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 127: Glance at 2010, 2015 and 2020 United Kingdom Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 128: United Kingdom Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 129: Glance at 2010, 2015 and 2020 United Kingdom Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

FRANCE

  • Chart 130: French Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 131: Glance at 2010, 2015 and 2020 French Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 132: French Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 133: Glance at 2010, 2015 and 2020 French Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

ITALY

  • Chart 134: Italian Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 135: Glance at 2010, 2015 and 2020 Italian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 136: Italian Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 137: Glance at 2010, 2015 and 2020 Italian Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

SPAIN

  • Chart 138: Spanish Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 139: Glance at 2010, 2015 and 2020 Spanish Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 140: Spanish Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 141: Glance at 2010, 2015 and 2020 Spanish Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

RUSSIA

  • Chart 142: Russian Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 143: Glance at 2010, 2015 and 2020 Russian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 144: Russian Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 145: Glance at 2010, 2015 and 2020 Russian Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

REST OF EUROPE

  • Chart 146: Rest of Europe Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 147: Glance at 2010, 2015 and 2020 Rest of Europe Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 148: Rest of Europe Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 149: Glance at 2010, 2015 and 2020 Rest of Europe Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

ASIA-PACIFIC

  • Chart 150: Asia-Pacific Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 151: Glance at 2010, 2015 and 2020 Asia-Pacific Biopharmaceuticals Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 152: Asia-Pacific Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 153: Glance at 2010, 2015 and 2020 Asia-Pacific Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 154: Asia-Pacific Monoclonal Antibodies (moAb) Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 155: Glance at 2010, 2015 and 2020 Asia-Pacific Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 156: Asia-Pacific Erythropoietin Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 157: Glance at 2010, 2015 and 2020 Asia-Pacific Erythropoietin Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 158: Asia-Pacific Biotech Vaccines Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 159: Glance at 2010, 2015 and 2020 Asia-Pacific Biotech Vaccines Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 160: Asia-Pacific Recombinant Human (RH) Insulin Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 161: Glance at 2010, 2015 and 2020 Asia-Pacific Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 162: Asia-Pacific Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 163: Glance at 2010, 2015 and 2020 Asia-Pacific Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 164: Asia-Pacific Interferons Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 165: Glance at 2010, 2015 and 2020 Asia-Pacific Interferons Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 166: Asia-Pacific Human Growth Hormones (HGH) Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 167: Glance at 2010, 2015 and 2020 Asia-Pacific Human Growth Hormones (HGH) Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 168: Asia-Pacific Other Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 169: Glance at 2010, 2015 and 2020 Asia-Pacific Other Biopharmaceuticals Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 170: Asia-Pacific Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 171: Glance at 2010, 2015 and 2020 Asia-Pacific Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas
  • Chart 172: Asia-Pacific Biopharmaceuticals in Neurology Therapy Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 173: Glance at 2010, 2015 and 2020 Asia-Pacific Biopharmaceuticals in Neurology Market Therapy Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 174: Asia-Pacific Biopharmaceuticals in Infectious Diseases Therapy Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 175: Glance at 2010, 2015 and 2020 Asia-Pacific Biopharmaceuticals in Infectious Diseases Therapy Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 176: Asia-Pacific Biopharmaceuticals in Diabetes Therapy Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 177: Glance at 2010, 2015 and 2020 Asia-Pacific Biopharmaceuticals in Diabetes Therapy Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 178: Asia-Pacific Biopharmaceuticals in Oncology Therapy Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 179: Glance at 2010, 2015 and 2020 Asia-Pacific Biopharmaceuticals in Oncology Therapy Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 180: Asia-Pacific Biopharmaceuticals in Cardiovascular Therapy Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 181: Glance at 2010, 2015 and 2020 Asia-Pacific Biopharmaceuticals in Cardiovascular Therapy Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 182: Asia-Pacific Biopharmaceuticals in Other Therapeutic Areas Market Analysis (2010-2020) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in US$ Million
  • Chart 183: Glance at 2010, 2015 and 2020 Asia-Pacific Biopharmaceuticals in Other Therapeutic Areas Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific

JAPAN

  • Chart 184: Japanese Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 185: Glance at 2010, 2015 and 2020 Japanese Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 186: Japanese Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 187: Glance at 2010, 2015 and 2020 Japanese Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

CHINA

  • Chart 188: Chinese Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 189: Glance at 2010, 2015 and 2020 Chinese Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 190: Chinese Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 191: Glance at 2010, 2015 and 2020 Chinese Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

INDIA

  • Chart 192: Indian Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 193: Glance at 2010, 2015 and 2020 Indian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 194: Indian Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 195: Glance at 2010, 2015 and 2020 Indian Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

REST OF ASIA-PACIFIC

  • Chart 196: Rest of Asia-Pacific Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 197: Glance at 2010, 2015 and 2020 Rest of Asia-Pacific Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 198: Rest of Asia-Pacific Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 199: Glance at 2010, 2015 and 2020 Rest of Asia-Pacific Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

SOUTH AMERICA

  • Chart 200: South American Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 201: Glance at 2010, 2015 and 2020 South American Biopharmaceuticals Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 202: South American Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 203: Glance at 2010, 2015 and 2020 South American Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 204: South American Monoclonal Antibodies (moAb) Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 205: Glance at 2010, 2015 and 2020 South American Monoclonal Antibodies (moAb) Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 206: South American Erythropoietin Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 207: Glance at 2010, 2015 and 2020 South American Erythropoietin Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 208: South American Biotech Vaccines Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 209: Glance at 2010, 2015 and 2020 South American Biotech Vaccines Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 210: South American Recombinant Human (RH) Insulin Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 211: Glance at 2010, 2015 and 2020 South American Recombinant Human (RH) Insulin Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 212: South American Granulocyte Colony-Stimulating Factor (G-CSF) Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 213: Glance at 2010, 2015 and 2020 South American Granulocyte Colony-Stimulating Factor (G-CSF) Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 214: South American Interferons Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 215: Glance at 2010, 2015 and 2020 South American Interferons Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 216: South American Human Growth Hormones (HGH) Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 217: Glance at 2010, 2015 and 2020 South American Human Growth Hormones (HGH) Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 218: South American Other Biopharmaceuticals Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 219: Glance at 2010, 2015 and 2020 South American Other Biopharmaceuticals Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 220: South American Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 221: Glance at 2010, 2015 and 2020 South American Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas
  • Chart 222: South American Biopharmaceuticals in Neurology Therapy Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 223: Glance at 2010, 2015 and 2020 South American Biopharmaceuticals in Neurology Market Therapy Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 224: South American Biopharmaceuticals in Infectious Diseases Therapy Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 225: Glance at 2010, 2015 and 2020 South American Biopharmaceuticals in Infectious Diseases Therapy Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 226: South American Biopharmaceuticals in Diabetes Therapy Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 227: Glance at 2010, 2015 and 2020 South American Biopharmaceuticals in Diabetes Therapy Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 228: South American Biopharmaceuticals in Oncology Therapy Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 229: Glance at 2010, 2015 and 2020 South American Biopharmaceuticals in Oncology Therapy Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 230: South American Biopharmaceuticals in Cardiovascular Therapy Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 231: Glance at 2010, 2015 and 2020 South American Biopharmaceuticals in Cardiovascular Therapy Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 232: South American Biopharmaceuticals in Other Therapeutic Areas Market Analysis (2010-2020) by Geographic Region - Argentina, Brazil and Rest of South America in US$ Million
  • Chart 233: Glance at 2010, 2015 and 2020 South American Biopharmaceuticals in Other Therapeutic Areas Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America

ARGENTINA

  • Chart 234: Argentine Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 235: Glance at 2010, 2015 and 2020 Argentine Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 236: Argentine Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 237: Glance at 2010, 2015 and 2020 Argentine Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

BRAZIL

  • Chart 238: Brazilian Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 239: Glance at 2010, 2015 and 2020 Brazilian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 240: Brazilian Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 241: Glance at 2010, 2015 and 2020 Brazilian Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

REST OF SOUTH AMERICA

  • Chart 242: Rest of South America Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 243: Glance at 2010, 2015 and 2020 Rest of South America Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 244: Rest of South America Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 245: Glance at 2010, 2015 and 2020 Rest of South America Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas

REST OF WORLD

  • Chart 246: Rest of World Biopharmaceuticals Market Analysis (2010-2020) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals in US$ Million
  • Chart 247: Glance at 2010, 2015 and 2020 Rest of World Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and Other Biopharmaceuticals
  • Chart 248: Rest of World Biopharmaceuticals Market Analysis (2010-2020) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas in US$ Million
  • Chart 249: Glance at 2010, 2015 and 2020 Rest of World Biopharmaceuticals Market Share (%) by Therapeutic Area - Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas
Back to Top